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Available online 10 October 2016Background: Neurobiological models of posttraumatic stress disorder (PTSD) implicate fear processing impair-
ments in themaintenance of the disorder. Speciﬁc deﬁcits in extinction recall, the retention of learned extinction,
have beendemonstrated.While deﬁcient extinction recall, and the associated activation pattern of prefrontal and
hippocampal regions, distinguishes individuals with PTSD from controls, research has not yet examined changes
following treatment. We examined the behavioral and neural correlates of extinction recall before and after cog-
nitive behavioral treatment of PTSD.
Methods: Fifty-eight participants (30 with PTSD, 28 trauma-exposed matched controls) underwent a 2-day be-
havioral fear conditioning, extinction, and recall paradigm during functional magnetic resonance imaging
(fMRI). The same procedures were repeated 10weeks later, after PTSD patients had completed prolonged expo-
sure treatment. We analyzed fMRI data from 32 subjects (16 PTSD; 16 controls) and skin conductance response
(SCR) data from 33 subjects (16 PTSD; 17 controls). Neural activity during extinction recall, SCR, and PTSD symp-
toms were compared across groups and over time.
Results: PTSD patients exhibited pre- to post-treatment reduction in rostral anterior cingulate cortex (rACC) ac-
tivation during extinction recall, and increase in functional coherence between the rACC and the ventromedial
prefrontal cortex (vmPFC) and subgenual anterior cingulate cortex (sgACC). Reduced PTSD symptom severity
from pre- to post-treatment was signiﬁcantly associated with reduced subgenual ACC and parahippocampal ac-
tivation during this task. SCR during the extinction recall phase did not signiﬁcantly changewith treatment in the
PTSD group, but change in SCR was associated with reduction in PTSD symptom severity.
Conclusions: Prolonged exposure treatment appears to alter neural activation in PTSD patients during recall of
fear extinction, and change in extinction recall (measured by SCR) is associatedwith symptom reduction.Wedis-
cuss results in the context of neural systems involved in response to affective stimuli.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).072833 (Dr. Neria, principal
stitutes of Health (NIH) grant
tric Institute & Department of
bia University, Unit #69, 1051
.
. This is an open access article under1. Introduction
Posttraumatic stress disorder (PTSD) is a chronic and serious disor-
der associated with suicidal risk, functional impairment, and medical
comorbidity (Breslau et al., 1998; Kessler, 1995; Shvil et al., 2014). Fear-
ful responses to trauma reminders in PTSD include intrusive thoughts
and feelings, avoidance of such reminders, and various alterations in
cognitions, mood, arousal, and reactivity (Diagnostic and Statistical
Manual of Mental Disorders, 5th Edition, 2013).
Neurobiological models of PTSD implicate fear and safety learning
processes in the persistence of, and recovery from, PTSD. Among thesethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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eralization (Lissek and Grillon, 2012), and difﬁculty in the maintenance
of learned fear extinction, also termed extinction recall (Milad et al.,
2008). Such impairments have been shown to distinguish PTSD from
non-PTSD controls (Jovanovic et al., 2013; Milad et al., 2008), but re-
search has yet to assess the relationship between changes in these im-
pairments and PTSD treatment. Testing whether PTSD treatments that
target fear processing deﬁcits enhance neural functioning in brain re-
gions associated with fear processing may meaningfully improve our
understanding of the underlying mechanisms and neural targets of
PTSD and its treatments. The current study examined whether
prolonged exposure (PE; Foa et al., 2007), a therapy targeting fear pro-
cessing through gradual habituation to traumatic memories and their
reminders through repetitive imaginal and in vivo exposure within a
safe context, enhanced extinction retention and associated neural
activations.
1.1. Neural underpinnings of extinction
Fear extinction refers to the ability to learn to suppress a fear re-
sponse to a previously conditioned stimulus (i.e., a stimulus previously
repeatedly presented paired with a fear eliciting cue, such as an electric
shock or a loud sound) through gradually reducing the fear-eliciting ca-
pacity of that stimulus by repeatedly presenting it with no paired fear-
eliciting cue (Sotres-Bayon et al., 2004). The neural circuits in fear learn-
ing have been well established through animal and human research.
They involve the amygdala, arguably the main subcortical structure in-
volved in emotional processing (Gallagher and Chiba, 1996; LeDoux,
2007; Phelps and LeDoux, 2005); several prefrontal cortical regions
(PFC), and the hippocampus. These areas, unsurprisingly, are involved
in fear extinction and extinction recall: medial prefrontal cortex
(mPFC), and speciﬁcally its ventral aspect (vmPFC), appear key to ex-
tinction learning. Neural activity in mPFC increases during extinction
learning (Milad and Quirk, 2002; Rosenkranz et al., 2003), direct electri-
cal stimulation of mPFC facilitates extinction learning (Garcia, 2002),
and vmPFC damage alters rats' capacity for extinction learning
(Morgan et al., 1993, 2003; Morgan and LeDoux, 1995; Quirk et al.,
2000). Research speciﬁcally implicates hippocampus in context learning
(Maren and Fanselow, 1995),with hippocampal inputs to vmPFC appar-
ently performing a gating function for extinction by providing contextu-
al information (Sotres-Bayon et al., 2004). Accumulating evidence
indicates themore speciﬁc involvement of vmPFC in the memory or re-
tention of learned extinction (i.e., extinction recall) (Lissek et al., 2013;
Milad et al., 2007).
1.2. Impaired extinction recall in PTSD
PTSDpatients exhibit impaired capacity to recall extinctionmemory,
as evinced by increased skin conductance responses (SCR) when previ-
ously extinguished fear stimuli are re-presented the next day (Milad et
al., 2009b). In functional magnetic resonance imaging (fMRI) studies,
PTSD patients have reduced hippocampal and vmPFC activation, and
greater dorsorostral ACC (drACC) activation, during extinction recall
(Milad et al., 2009a,b; Shvil et al., 2014), possibly indicating lower ca-
pacity for regulation of fear response.
1.3. Extinction-based treatment for PTSD
Several behavioral therapies for anxiety disorders purportedly rely
on extinction via habituation through repetitive exposure to threaten-
ing cues, memories, or events within a safe context (Rothbaum and
Davis, 2003), and an extinction of conditioned fear task may be consid-
ered a laboratory analog of exposure procedures in psychotherapies
such as PE, a ﬁrst line psychotherapy for PTSD (Blechert et al., 2007;
Bouton et al., 2001). Although PE beneﬁtsmanypatients, almost half ex-
hibit persistent PTSD (Ponniah and Hollon, 2009). Elucidating whetherPE treatment reverses extinction deﬁcits and normalizes activity in as-
sociated neural circuitry would advance understanding of the neural
basis of PTSD and provide a clinically meaningful biological marker of
treatment response.
1.4. Functional neural changes following treatment of PTSD
Several studies examined functional brain changes after treatment
among patients with PTSD. Findings include increased activation in var-
ied fear-related structures: lateral (Farrow et al., 2005; Felmingham et
al., 2007; Lansing et al., 2005; Peres et al., 2007b) and medial (Peres et
al., 2007b, 2011) prefrontal regions; anterior cingulate cortex (ACC)
(Felmingham et al., 2007; Peres et al., 2007b), thalamus (Peres et al.,
2007b; Peres et al., 2011), and hippocampus (Felmingham et al., 2007;
Peres et al., 2007b). Decreased activation following psychotherapy
was found in lateral prefrontal structures (Lindauer et al., 2007), insula
(Aupperle et al., 2013; Peres et al., 2007a, 2011), thalamus (Lansing et
al., 2005), and amygdala (Felmingham et al., 2007; Peres et al., 2007b,
2011). Although highly informative in deﬁning medial and lateral pre-
frontal regions, as well as emotion-related subcortical structures, as
ROIs in PTSD treatment, these studies have limitations. Treatments
and activation tasks have varied across studies; only a few studies
used fMRI (Farrow et al., 2005; Felmingham et al., 2007; Peres et al.,
2011), and none to date employed a fear learning-extinction-retention
task before and after treatment, or prolonged exposure therapy.
1.5. Current study aims
This study sought to address gaps in knowledge by examining
whether: 1) PE improves extinction recall and related neural changes
in circuitry associated with fearful emotional response (e.g., mPFC,
ACC, amygdala, and hippocampus), and 2) neural and psychophysiolog-
ical changes in extinction recall are associated with clinical improve-
ment. We hypothesized that: 1) Physiological response during
extinction recall (skin conductance) would decrease following treat-
ment; 2) Hippocampal and vmPFC activation would increase, and ros-
tral ACC activation would decrease, during extinction recall; and 3) all
of these changes would be associated with reduction in PTSD symp-
toms. To test these hypotheses we used fMRI and an established 2-day
extinction learning and recall paradigm (Graham and Milad, 2013;
Milad et al., 2005, 2009a,b, 2013) to assess psychophysiological and
neural changes post PE treatment. Functional MRI data were acquired
simultaneously with fear extinction recall quantiﬁed physiologically
by skin conductance response (SCR). All PTSD, and control subjects re-
peated these procedures 10 weeks later, after PTSD subjects had com-
pleted 10 weeks of PE treatment.
2. Materials and methods
2.1. Participant recruitment and assessments
PTSD patients and trauma-exposed, medically healthy controls (TE-
HC) matched on gender, age at exposure to trauma, trauma type (inter-
personal vs. non-interpersonal) and duration, race, and ethnicity, were
recruited via advertisement and ﬂiers. All participants met DSM-IV
PTSD criterion A1 for adult traumatic events, including vehicular acci-
dents, sexual or physical assaults, and witnessing serious injuries or
deaths. Medical history, review of systems, physical examination, and
laboratory tests determined all participants' health status. Three trained
raters administered the Structured Clinical Interview for DSM-IV Axis I
Disorders (SCID), Hamilton Depression Rating Scale (HAM-D-17;
Hamilton, 1960), and Clinician-Administered PTSD Scale (CAPS; Blake
et al., 1995) for DSM-IV to assess PTSD diagnosis and clinical severity.
A senior clinician trained raters to administer these instruments, and
interrater reliability scores, obtained by pairs of the three participating
Table 1
Demographic and clinical characteristics of completers.
TEHC (N=
28)
PTSD (N=
30)
F(1,
58) pM SD M SD
Age (years) 35.61 9.36 35.31 9.89 0.06 0.81
Education (years) 16.11 1.77 14.53 2.06 9.65 0.00
CAPS 5.15 6.39 78.53 16.31 463.97 0.00
HAM-D 2.42 2.60 16.07 5.46 135.64 0.00
Primary trauma age (years) 26.43 9.45 28.90 10.02 0.93 0.34
Life events-count of all events 2.46 2.47 3.80 4.40 1.99 0.16
Reduction in CAPS over the course
of 10 weeks (%)
12.56 136.30 64.00 29.99 3.84 0.06
N % N % χ2 p
Sex 0.03 0.55
Female 20 71.43% 22 73.33%
Male 8 28.57% 8 26.67%
Ethnicity 4.41 0.33
White 10 35.71% 9 30.00%
Asian or Paciﬁc Islander 1 3.57% 1 3.33%
Hispanic 9 32.14% 14 46.67%
Black 8 28.57% 4 13.33%
Other 0 0.00% 2 6.67%
Note: CAPS = Clinician Administered PTSD Scale; HAM-D= Hamilton Depression Rating
Scale 17 item score; CAPS and HAM-D scores indicate severity of symptoms (e.g., higher
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instruments.
PTSD subjects, included only following clinician diagnosis of PTSD
and CAPS score of≥50, were excludedwith diagnosis of psychosis, sub-
stance/alcohol dependence within the past six months or abuse within
past two months, use of any psychotropic medication in the 4 weeks
preceding participation (6 weeks for ﬂuoxetine), or HAM-D-17
score N 24. TE-HC exclusion criteria were any current or past Axis I dis-
orders, and CAPS score N 19 (considered symptomatic) (Blake et al.,
1995). The New York State Psychiatric Institute Institutional Review
Board approved all procedures, and all participants providedwritten in-
formed consent for this clinicaltrials.gov-registered trial (identiﬁer
NCT01576510). Eighty-ﬁve participants consented (PTSD = 48), in-
cluding 57 women, with a mean age of 35.73 years (SD = 10.20) and
a primary trauma (on which treatment would focus) that occurred a
mean of 7.80 (SD = 7.60) years prior to treatment. Participants had
been exposed to a mean 3.20 (SD = 3.50) traumatic events.
Dropout yielded a completer sample of 58 subjects: 30 patients with
PTSD and 28 TE-HCs (Fig. 1). PTSD and TE-HC participants were
matched for age, gender, and ethnicity, and the completer samples
also did not differ on these variables; see Table 1. Dropouts and com-
pleters did not differ signiﬁcantly on any clinical or demographic
variables.score corresponds to worse symptoms); Questions regarding trauma adapted from the
PTSD module used in the National Comorbidity Study (Kessler et al., 1995).2.2. Treatment
PTSD patients entered treatment with one of two trained therapists
who adhered to the 10-week standard PE protocol (Foa et al., 2007),
wherein patients repeatedly recount the traumatic experience
(imaginal exposure) and confront previously avoided trauma re-
minders (in vivo exposure) to extinguish fear responses. Therapists
had treated two pilot cases under supervision to conﬁrm expertise
and were continuously monitored and supervised by PE experts for
adherence and competence. To this end, independent assessors
used the PE integrity measure (Foa et al., 2005) to rate audiotaped
sessions.Fig. 1. Participant retention throughout the study. Note: PTSD = Posttraumatic stress disord
conductance response; MRI = magnetic resonance imaging. *Differences in numbers between
wait period, and 2 did not complete end of treatment assessment). **Note: SCR and fMRI data2.3. Task procedures
An established computer-based paradigm, completed in the MR
scanner, was used to assess fear conditioning and extinction on day 1
and extinction recall on day 2 (Milad et al., 2007). The three conditioned
stimuli (CSs), presented on a screen, were differentiated by the color of
a lamp (red, blue, or yellow), which turned on and off in two different
rooms. A 500 ms shock delivered via electrodes attached to the second
and third ﬁngers of the dominant hand served as the unconditioned
stimulus (US). Participants selected the US intensity, ranging from 0.8
to 4.0 mA, following instructions to choose a level that was highlyer; TE-HC = trauma exposed healthy controls; PE = prolonged exposure; SCR = skin
stages due to drop out (3 after consent, 8 after baseline assessment, 6 during treatment/
overlap included: 11 TE-HC and 6 PTSD participants.
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averaging 2.7 mA (SD = 1.2) for the pre-treatment session and 2.7 mA
(SD= 1.1) for the post-treatment session. Shock levels were compared
using t-tests and did not differ between the two sessions (p= 0.93) or
between the PTSD and TE-HC groups (p=0.17 pre-treatment, p=0.98
post-treatment). Following theUS calibration, a habituation phase com-
prised 12 counterbalanced CS trials (4 of each of the three CS types).
During the conditioning phase, each of the two CS + s (red and blue
lights) was paired with the US at a partial reinforcement rate of 62.5%.
One of the CS + s was extinguished during the subsequent extinction
phase on Day 1 (CS + E), while the other was not extinguished
(CS + NE). The two CS + s were presented in blocks of eight trials (8
CS + E, and 8 CS + NE) intermixed with eight CS− (yellow light) pre-
sentations that were never paired with the US, for a total of 16 trials (8
for each CS). After conditioning, a 5-min gap preceded the onset of ex-
tinction training, which consisted of 16 unreinforced presentations of
CS + E intermixed with 16 presentations of the CS−. On day 2, partic-
ipants were tested for extinction recall with blocks of 8 trials of the
extinguished CS + E, and 8 trials of the non-extinguished CS + NE
intermixed with an equal number of CS− trials in each block,
counterbalanced between subjects. Shock electrodes remained attached
to the subject's ﬁngers through the entire experiment, and subjects
were told, “You may or may not receive an electric shock.” The mean
inter-trial interval was 15 s (range: 12–18 s).
2.4. Skin conductance response (SCR) assessment
Skin conductance responses (SCR) for each CS trial were calculated
by subtracting themean skin conductance level (SCL) during the 2 s pe-
riod before CS onset from the peak SCL during the 6 s CS duration (Milad
et al., 2009a,b). Further, the rawSCRwere square root transformed prior
to analysis.
Conditioningwas assessed by comparing themean SCR amplitude of
all CS+ trials with themean SCR amplitude of all CS− trials, and extinc-
tion was assessed by comparing the mean SCR amplitude of the last 8
CS+ trials with the mean SCR amplitude of the last 8 CS− trials for
the extinguished stimulus only (Marin et al., 2016; Milad et al., 2013).
Extinction recall was assessed by subtracting the mean SCR amplitude
of the ﬁrst 4 CS + E (not extinguished CS+) trials from the ﬁrst 4
CS + NE (extinguished CS+) trials (Milad et al., 2009a,b).
2.5. fMRI assessment
All images were acquired on a 1.5 T GE Twin Speed MR Scanner op-
erating on the Excite 3 12.0 M4 HD platform using an 8-channel head
coil. An Integrated Functional Imaging System (IFIS, MRI Devices
Corp.) synchronized the behavioral paradigmwith scanning and stimuli
presentations. A high-resolution T1-weighted 3D MPRAGE sequence
was acquired for each subject for spatial normalization and anatomical
localization (repetition time = 7.25 ms, echo time = 3 ms, Flip
angle = 7°, ﬁeld of view= 25.6 cm, 256 × 256 pixel matrix, slice thick-
ness = 1 mm). Functional MRI images (using blood oxygenation level
dependent [BOLD] contrast) were acquired using gradient echo T2*-
weighted sequence (TR/TE/Flip angle = 3 s/30 ms/90° [Kwong et al.,
1992]). The functional imageswere collected in the same plane (45 cor-
onal oblique slices parallel to the anterior-posterior commissure line,
tilted 30 anterior, 3 × 3 × 3 mm voxels). Identical scanning procedures
were conducted on Day 1 and Day 2.
2.6. Statistical analyses
Quality control assessment was performed on the skin conductance
data. Due to data corruption (4 PTSD, no TE-HC) and lack of response to
the UC stimulus (SCR b 0.05) during the conditioning phase (10 PTSD,
11 TE-HC), a total of 25 participants were excluded from the SCR analy-
ses (for exclusion of data points at different study stages, see Fig. 1).Analyses examining potential differences between SCR responders and
non-responders revealed no group differences (see Table S1 in Supple-
mentary Materials).
To examine whether participants exhibited intact conditioning and
extinction, separate analyses were conducted for each phase at baseline
[N= 47 (24 PTSD)] and follow-up [N= 42 (20 PTSD)] with mixed-ef-
fects ANOVAs used to test the effect of Group, Stimulus, and Group-by-
Stimulus interaction. To gauge SCR pre-to-post-treatment changes dur-
ing the recall phase, a mixed-effects ANOVA was conducted with Time
as a within-subject repeated measure, Group as a between-subject var-
iable, and Recall (deﬁned above) as the dependent variable [N=46 (24
PTSD) at baseline, N=39 (18 PTSD) at follow-up], with Time-by-Group
interactions included in the model for the 33 participants (16 PTSD)
with complete data for both time points. Difference between pre- and
post-treatment SCR, operationalized as pre-to-post change in recall,
was then correlated with change in PTSD symptom severity (CAPS
total score) to gauge the relationship between changes in recall and
changes in symptoms following treatment.
Prior to analyses, all fMRI images were preprocessed using standard
procedures in SPM8. All images were slice-time and motion corrected,
and coregistered to their own structural images. The coregistered im-
ages were warped into MNI space and smoothed with an 8 mm full-
width half-max kernel. All analyses were performed on the smoothed
images. A general linear model (GLM) was ﬁt separately for each sub-
ject, with task-related regressors created using SPM's canonical dou-
ble-gamma hemodynamic response function. Each subject-speciﬁc
GLM included regressors to control for headmotion (24 per run, includ-
ing 6motion regressors derived from realignment parameter estimates,
squared motion estimates, and squared derivatives), as well as dummy
regressors to account for outlier images identiﬁed as having a signiﬁ-
cantly greater Mahalanobis distance compared to the other images
(FDR-corrected p b 0.05). Within-subject contrasts were generated for
each subject separately for extinction recall (ﬁrst four CS + E vs. ﬁrst
four CS + NE). These contrasts parallel those used in the SCR analy-
ses. Paired t-tests were performed for each group separately, TEHC
and PTSD, to compare differences between baseline and follow-up
activations. For all fMRI analyses, an initial threshold of p b 0.005
with a minimum of 10 contiguous voxels was used to identify signif-
icant activations within the nodes of the fear extinction network.
Small volume corrections were then performed, and only results
surviving family-wise error (FWE) corrections of p b 0.05 are
reported.
Seventeen participants (11 PTSD, 6 TEHC) were excluded from the
baseline fMRI analyses, and 15 participants (9 PTSD, 6 TEHC) were ex-
cluded from the follow-up fMRI analyses, leaving 16 TE-HC and 16
PTSD participants with complete pre/post data. Participants were ex-
cluded due to artifacts in images caused by a radiofrequency noise
leak in the shock-delivery equipment, which was subsequently ad-
dressed. They were thus not excluded for reasons related to group sta-
tus, symptom severity, or treatment effects, and available evidence
indicates that they are missing at random.We compared demographic,
clinical, and SCR data between subjects included (n = 32) and those
omitted from the analysis (n=26), ﬁnding no differences.We conduct-
ed psychophysiological interactions (PPI) analyses for the PTSD cohort,
including only subjects who had fMRI data for the recall phase at both
baseline and follow-up (n = 16). As a seed, we used the region that
showed a signiﬁcant change from baseline to follow-up during recall
(contrast CS + E vs CS + NE) in that same cohort (right rACC, see the
Results section). The seed was deﬁned as a 5 mm sphere centered
around the peak voxel resulting from that contrast (MNIxyz = 16, 42,
20). We then performed PPI analyses using the generalized PPI toolbox
(McLaren et al., 2012) for each subject at baseline and at follow-up dur-
ing recall for the contrast CS+ E vs eCS+NE. These ﬁrst-level maps for
each individual subject were used to build a second-level map, where
positive activations and negative activations relative to the seed were
performed at baseline vs. follow-up contrast. We used an initial
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tify signiﬁcant activations within the nodes of the fear extinction net-
work. Small volume corrections were then performed, and only
results surviving family-wise error (FWE) corrections of p b 0.05 are re-
ported. All contrasts were tested within predeﬁned ROIs including
amygdala, hippocampus, insula, subcallosal cortex, medial prefrontal
cortex (mPFC), OFC, ACC, thalamus, and vmPFC. ROIs were created
with the anatomical 70% FSL Harvard-Oxford maximum likelihood cor-
tical and subcortical atlases.
3. Results
3.1. Change in PTSD symptoms following treatment
Amixed-effects ANOVA of PTSD symptom severity assessed by CAPS
at baseline and week 10 (posttreatment for PTSD group) showed a sig-
niﬁcant effect of Group (F(1, 49)= 186.80, p b 0.001), Time (F(1, 49) =
89.00, p b 0.001), and a Group-by-Time interaction (F(1, 49) = 87.72,
p b 0.001). Pairwise LSD tests between the groups showed a signiﬁcant
difference in CAPS total scores at baseline (mean difference = 73.95,
SE = 3.68, p b 0.001) and at follow-up (mean difference = 24.20,
SE = 5.13, p b 0.001). Pairwise LSD tests between time points showed
signiﬁcant reduction in CAPS total score in the PTSDgroup (meandiffer-
ence = 49.93, SE = 3.49, p b 0.001), but not the TEHC group (M differ-
ence = 0.18, SE = 4.01, p= 0.96).
3.2. SCR measures of fear acquisition and extinction
At baseline, both groups conditioned to the stimuli paired with
shock, demonstrating signiﬁcantly highermean SCRs across the 16 trials
of both CS+ relative to CS− (F(1, 45) = 57.48, p b 0.001). There were
no signiﬁcant effects of Group (p N 0.56), or Group-by-Stimulus interac-
tion (p= 0.42), suggesting similar group conditioning.
At follow-up, both groups again conditioned to the stimuli paired
with shock, demonstrating signiﬁcantly higher mean SCRs across the
16 trials of both CS+ relative to CS− (F(1, 40) = 18.78). There were
no signiﬁcant effects of Group (p = 0.24), or Group-by-StimulusFig. 2. Psychophysiological activation during extinction recall at basinteraction (p= 0.37), again suggesting similar conditioning between
the groups. Across both time points there was a signiﬁcant effect of
Stimulus (F[1, 34] = 45.81, p b 0.001), and a nonsigniﬁcant trend of re-
duced conditioning over Time (F[1, 34]= 3.81, p=0.06). Neither an ef-
fect of Group (F[1, 34] = 0.80, p = 0.38) nor signiﬁcant interactions
were observed (all p N 0.08). Thus, the two groups apparently acquired
fear conditioning equally well before and after treatment, with no dis-
cernable change (Fig. S1a).
At baseline, a comparison of the last eight extinction trials of the
CS + E versus the last eight trials of the CS− showed no effect of Stim-
ulus (p = 0.12), Group (p = 0.98), or Group-by-Stimulus interaction
(p = 0.28), suggesting comparable SCR levels following extinction
across both groups. At follow-up there was no signiﬁcant effect of Stim-
ulus (p=0.13), or Group (p=0.66), or a Group-by-Stimulus interaction
(p= 0.44). Across time points there was a signiﬁcant effect of Stimulus
(F[1, 34] = 5.16, p = 0.03). No effect of Group (p = 0.48), Time (p =
0.08), or any interactions (all p N 0.29) were observed. Thus, the two
groups extinguished equally well before and after treatment, without
discernable change (Fig. S1b).
3.3. Fear extinction recall
3.3.1. SCR measures
Although repeated-measures ANOVA of change in extinction recall
over time by group revealed no signiﬁcant Time (p = 0.637), Group
(p = 0.178) or Time-by-Group (p = 0.620) effects, the PTSD group
showed non-signiﬁcantly higher recall index at pre-treatment than
did TE-HCs (p= 0.130), and the two groups were comparable at post-
treatment (p=0.420), indicating potential normalization of extinction
recall over time (Fig. 2).
3.3.2. Change in neural activation during extinction recall
Analyses of BOLD data showed greater baseline activation of the
right rACC in the PTSD group at baseline relative to follow-up
[MNIxyz = 16, 42, 20, t(15) = 3.79, cluster size = 23, p = 0.021,
FWE corrected]. The TEHC group showed less activation in the lefteline and after 10 weeks in PTSD (treated) and TE-HC groups.
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Fig. 3. Change in neural activation during extinction recall following treatment among
PTSD and TE-HC groups. Note: PTSD = posttraumatic stress disorder; TE-HC = trauma
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t(15) = 3.76, cluster size = 61, p= 0.019, FWE corrected]; see Fig. 3.3.3.3. Relationships between physiological activation during extinction re-
call and change in PTSD symptoms
The PTSD group showed a signiﬁcant positive correlation between
decrease in the extinction recall index and the percent decrease in
CAPS (r = 0.57, p = 0.02; Fig. 4), indicating signiﬁcant associationFig. 4. Correlation between change in SCR and change in CAPS score. Note: SCR = skin conduc
conditioned stimulus; CAPS = clinician administered posttraumatic symptom scale. Summa
pre- to post-treatment showed the largest decrease in CAPS.between improvement in psychophysiological indicator of extinction
retention and symptom reduction.3.3.4. Relationships between neural activation during extinction recall and
change in PTSD
Relationships between pre- vs. post-treatment changes in neural ac-
tivation during recall and CAPS changes among PTSD group members
appeared in several regions: Decreased activation from pre- to post-
treatment in the right subgenual ACC (sgACC, MNIxyz = 6, 6, −16),
and in left hippocampal and parahippocampal region (MNIxyz =−16,
16,−12,−14), were signiﬁcantly associated with percent decrease in
CAPS score [t(15) = 4.29, cluster size = 84, p=0.017 (FWE corrected)
for sgACC and t(15) = 4.00, cluster size = 45 p = 0.011 (FWE
corrected) for the hippocampus/parahippocampus].
Secondary analyses correlating symptom change and change in acti-
vation associatedwith the rACC seed (region noted above to signiﬁcant-
ly change during extinction recall) did not signiﬁcantly relate to CAPS
(see supplemental materials).3.3.5. Functional neural connectivity
Comparing activation during extinction recall at baseline vs. follow-
upwithin the PTSD group, we found that the rACC seed exhibited great-
er functional coherence at follow-up with the following regions: left
rACC [MNIxyz = −2, 30, −8, t(15) = 4.10, cluster size =52, p =
0.008 (FWE corrected)], vmPFC [MNIxyz = −14, 48, −18, t(15) =
5.25, cluster size = 154, p = 0.004 (FWE corrected)], and sgACC
[MNIxyz =−10, 20,−20, t(15) = 4.87, cluster size = 217, p = 0.01
(FWE corrected)].
These ﬁndings suggest that rACC regions showing signiﬁcant change
in activation from pre- to post-treatment also exhibited signiﬁcant in-
creases in functional coherencewith ventral prefrontal regions (namely
an additional seed in the ventral rACC, sgACC and vmPFC) following
treatment (see Fig. 5). For more information regarding functional con-
nectivity at pre- and post-treatment, see supplementary materials:
Functional connectivity of ROIs and Table S2.tance response; CS + E = extinguished conditioned stimulus; CS + U = unextinguished
ry: individuals with the largest change in extinction recall SCR (CS + E− CS + U) from
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This study demonstrates, for the ﬁrst time, changes in neural circuits
and psychophysiology related to fear extinction recall following PE
treatment for PTSD. Findings partially support our hypotheses, indicat-
ing a PTSD group speciﬁc post-treatment decrease in right rACC activa-
tion during extinction recall. The TEHC group showed a reduction in
vmPFC activation at 10-week follow-up, possibly indicating habituation
to the task. This change was not seen in the PTSD group. The ﬁnding of
change in rACC activation during PE accords with our previous ﬁndings
of decreased cortical thickness and volume in rACC among remitters fol-
lowing PE, in a partly overlapping sample (Helpman et al., 2016). To-
gether, these ﬁndings suggest that PE treatment of PTSD may affect
rACC structure and function, evoking the possibility of treatmentmech-
anism working through this region. The change in rACC activationFig. 5. Psychophysiological interactions during extinction recall phase between seed regionwith
rostral anterior cingulate seed identiﬁed as decreasing in activation during extinction recall p
activation when activation in the seed region increases during extinction recall; Negative coup
increases during extinction recall; Pre N Post — coupling between marked areas and seed decr
increase from pre-to-post-treatment.during recall found here correlatedwith enhanced functional coherence
with additional ventral prefrontal areas such as the vmPFC and sgACC.
This pattern suggests, that during recall, rACC may work in synchrony
with ventral aspects of prefrontal cortex downregulating fear circuitry,
possibly in coordination with hippocampus: hippocampal activity was
associated with post-treatment symptom change. However, we were
not able to directly demonstrate treatment-related changes in activation
of the vmPFC andhippocampus during extinction recall. Ourﬁndings fur-
ther suggest that both physiological (SCR) and neural (fMRI activation)
changes during recall following treatment signiﬁcantly were correlated
with reduction in PTSD symptoms, indicating potential mechanistic
connections between these changes and clinical improvement. This ech-
oes ﬁndings by Felmingham and colleagues (Felmingham et al., 2007)
who also found increased rACC activation and decreased amygdalar acti-
vation during processing of fearful vs. neutral faces after exposure-basedidentiﬁed pre-to-post-treatment changes and additional regions of interest. Note: Seed=
hase from pre-to-post-treatment; Positive coupling = marked region evinces increased
ling = marked region evinces reduction in activation when activation in the seed region
ease from pre-to-post-treatment; Post N Pre — coupling between marked areas and seed
722 L. Helpman et al. / NeuroImage: Clinical 12 (2016) 715–723cognitive behavioral therapy for PTSD. Although couplingwith amygdala
failed to reach signiﬁcance in our sample, our ﬁndings of changes in pre-
frontal activation and its synchrony with hippocampus may indicate
improvement in discrimination, using contextual information from
hippocampus, and further illuminate the mechanisms behind this
change.
The masked whole brain analyses linking post-treatment changes
with symptom improvement support the relationship between neural
mechanisms related to extinction recall and posttraumatic symptoms:
sgACC, parahippocampal, and hippocampal region decreases in activa-
tion correspond to decreases in symptoms, which in turn correspond
to improvement in physiological measures of extinction recall.
Our rACC and connectivity ﬁndings are congruent with ﬁndings
showing consistent resting-state ACC hyperactivity in PTSD patients
compared to healthy controls (Koch et al., 2016) and data indicating re-
duced default mode network intra-network connectivity in PTSD
(Sripada et al., 2012). They also dovetail with previous accounts of
two neural systems, ventral and dorsal, acting in emotional perception
and response (Phillips et al., 2003). We demonstrate here that these
patterns normalize with treatment, showing reduced rACC activation
and increase in its functional coherencewith other regions of thedefault
mode network. Additionally, we demonstrate that ventral (“identiﬁca-
tion and reactivity”) system decreases in activation during recall corre-
late with symptom reduction. Thus, changes in neural activation during
extinction recall following treatmentmay reﬂect decreased “ﬂagging” of
stimuli as dangerous or affect-laden, thus lowering reactivity to threat
cues, and enhancing ability to retain extinction memory, as treatment
gains. We did not include dorsal (“regulation”) system activation in
the ROIs in this study. Thus, we conclude that, although prolonged ex-
posure treatment produces signiﬁcant changes in neural activation pat-
terns associated with the ability to retain extinction of fear, the
relationship between this ability and posttraumatic symptomatology
is complex and may involve changes in additional neural systems be-
yond the scope of this investigation.
Our ﬁndings, while robust in demonstrating signiﬁcant changes in
psychophysiology corresponding to symptoms and in neural function
during extinction recall following PE treatment for PTSD, have limita-
tions. Due to attrition and technical issues, our ﬁnal sample for fMRI
pre-post contrasts included only 16 individuals per group, limiting gen-
eralizability of ﬁndings. Replication is also needed. This small sample
size precluded sufﬁcient power for interaction analyses (see supple-
mentarymaterials) and additional analyses of subgroups, such as remit-
ters vs. non-remitters (Helpman et al., 2016) or males vs. females,
which have shown divergent patterns in fear acquisitions, extinction
and recall (Hwang et al., 2015; Milad et al., 2009a,b; Shvil et al., 2014).
Future studies should address these issues, as well as test for speciﬁcity
of ﬁndings for PE (in comparison to a different treatments). Nonethe-
less, our ﬁndings support the idea that prolonged exposure treatment
may produce a host of neural and psychophysiological changes leading
to clinical improvement of PTSD.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nicl.2016.10.007.
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